Pfizer
Biotech

Pfizer beats out Novo with $10B agreement to buy Metsera

After a chaotic bidding clash that only burst out into public view nine days ago, Pfizer has prevailed in its pursuit of obesity biotech Metsera.
Eric Sagonowsky Nov 8, 2025 8:11am
Martin Makary FDA Senate HELP confirmation

FDA reveals 2nd round of 'national priority' voucher winners

Nov 6, 2025 3:12pm
Factions emerging in government
Favicon Fierce Healthcare

Government shutdown updates: Schumer's latest proposal

Nov 7, 2025 4:15pm
money bag of money cash sack of money

Novo CEO tells Pfizer to 'bid higher' if it wants to win Metsera

Nov 7, 2025 10:00am
parasailing over clouds in Salzburg Austria

Recursion refreshes leadership with CEO swap—Chutes & Ladders

Nov 7, 2025 8:30am
reshuffle pipeline target reorganize shift change

Sana, CAMP4 ditch clinical-stage assets for preclinical hopefuls

Nov 7, 2025 8:13am
More News

Patient dies after receiving Intellia's CRISPR therapy

Nov 7, 2025 5:25am

Experiments reveal targets for new tuberculosis vaccines

Nov 7, 2025 5:15am

Cullinan puts kibosh on 2 cancer assets amid autoimmune refocus

Nov 6, 2025 1:26pm

Axsome adds AZ asset through Avenue subsidiary acquisition

Nov 6, 2025 10:50am